发明名称 |
CONTINUOUS ARYCYCLIC COMPOUND |
摘要 |
This is to provide a continuous arycyclic compound having a DGAT1 inhibitory activity, and useful for prophylaxis and/or treatment of obesity or hyperlipidemia caused by obesity, hypertriglyceridemia, lipid metabolism disorder, fatty liver, hypertension, arteriosclerosis, diabetes, etc., as well as to provide a DGAT1 inhibitor comprising the continuous arycyclic compound or a pharmaceutically acceptable salt thereof as an effective ingredient. Disclosed is the continuous arycyclic compound is represented by the formula: wherein the substituents in the formula are the same as defined in the specification, or a pharmaceutically acceptable salt thereof. |
申请公布号 |
HK1188597(A1) |
申请公布日期 |
2015.08.21 |
申请号 |
HK20140101634 |
申请日期 |
2014.02.20 |
申请人 |
MITSUBISHI TANABE PHARMA CORPORATION |
发明人 |
SAKURAI, OSAMU;SARUTA, KUNIO;HAYASHI, NORIMITSU;GOI, TAKASHI;MOROKUMA, KENJI;TSUJISHIMA, HIDEKAZU;SAWAMOTO, HIROAKI;SHITAMA, HIROAKI;IMASHIRO, RITSUO |
分类号 |
C07D;A61K;A61P |
主分类号 |
C07D |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|